

theranos.com
theranos.com
Get leads like Theranos — and thousands more
Build targeted lists by tech stack, traffic, and more
Theranos.com: The Digital Ghost of Unicorn Graveyard
An autopsy of a $1.4B failure through the lens of its forgotten digital footprint
The domain theranos.com still resolves. That alone is a miracle of digital negligence—a tombstone left standing in the graveyard of failed unicorns. While Holmes awaits sentencing, her website tells a different story: one of catastrophic product-market disconnect that every founder should study.
"Theranos didn't fail because they built the wrong product—they failed because they built NO product. The website was the only working part."
The Phantom Infrastructure
With zero technologies detected and a tech stack that literally doesn't register, theranos.com is the perfect metaphor for the company: a beautiful facade with nothing behind it. The 206 monthly visits are likely journalists, law students, and the morbidly curious—people checking if the site still exists. For a company that claimed to revolutionize blood testing, the digital presence was shockingly primitive. No product demos, no whitepapers, no technical specs—just marketing fluff that fooled investors for years.
The Inverted Growth Curve
Real biotech companies grow traffic with scientific breakthroughs and FDA approvals. Theranos.com's traffic spike came from scandal, not innovation. The 206 visits represent the digital equivalent of a crime scene—forensic traffic from people trying to understand how $1.4B evaporated. Compare this to modern biotech startups: even failed ones maintain 10K+ monthly visits from genuine scientific interest. This traffic pattern reveals the core truth: Theranos was never a tech company, it was a narrative company.
The single listed employee—Brooke Harding, Phlebotomist—is either a data artifact or the most tragic job title in Silicon Valley history. One phlebotomist for a company claiming to process thousands of blood tests per day. The math doesn't just not add up; it actively mocks the concept of scale. This is what due diligence failure looks like in data form.
- Zero technologies detected on their site: The ultimate red flag that investors missed
- 206 monthly visits: Less traffic than most local restaurants
- Single employee listed: A phlebotomist for a $1.4B unicorn
- No organic keywords: Because you can't rank for products that don't exist
The Website Was The Product
Theranos.com was never meant to serve users—it was designed to be just credible enough to fool the next round of investors. For founders: if your website has more traffic from prosecutors than customers, you're not building a company, you're building an exhibit.
How much traffic does Theranos get?
Traffic & Engagement
What is Theranos's revenue?
Who works at Theranos?
Loading leads...
What do customers think of Theranos?
Theranos
Categories
Activity & Engagement
Contact Information
Reviews (0)
No reviews found. Reviews may not be available in the initial page load. Try refreshing or check the Trustpilot page directly.
Frequently Asked Questions about Theranos
What is Theranos's Revenue?
How fast is Theranos growing?
Who are Theranos's competitors?
What do customers think of Theranos?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
Export theranos.com Data
Download the complete tech stack, analytics, leads, and company data for theranos.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About theranos.com
Company Overview
Traffic & Audience
theranos.com receives approximately 206 monthly visitors. The website has a bounce rate of 100% with visitors viewing an average of 1.0 pages per visit. Users spend an average of 0:00 on the site.
Frequently Asked Questions
What is theranos.com?
How popular is theranos.com?
Related Searches
This page provides publicly available information about theranos.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit theranos.com directly at https://theranos.com.